Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172038 | SCV000054821 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV000765155 | SCV000896384 | uncertain significance | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089357 | SCV001002472 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172038 | SCV001788593 | likely benign | not provided | 2020-06-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31983221, 23861362) |
Ambry Genetics | RCV002354432 | SCV002621017 | likely benign | Cardiovascular phenotype | 2021-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |